Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4330 | Ordered by Date (descending)
1 2 3 ... 42 43 44  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Exscientia Ltd.. (5/26/20). "Press Release: Exscientia Raises $60 Million in Series C Financing Round Led by Novo Holdings". Oxford, Copenhagen & Hamburg. 2020-05-26
HotSpot Therapeutics, Inc.. (5/21/20). "Press Release: HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines". Boston, MA. 2020-05-21
GlaxoSmithKline plc. (5/21/20). "Press Release: GSK Partners with Samsung Biologics to Secure Additional Manufacturing Capacity for Innovative Biopharmaceutical Portfolio". London & Songdo. 2020-05-21
Rentschler Biopharma SE. (5/19/20). "Press Release: Rentschler Biopharma Licenses Horizon Discovery's CHOSource Platform to Complement Cell Line Development Offering for Difficult-to-Express Proteins". Laupheim, Milford, MA & Cambridge. 2020-05-19
Holmusk. (5/18/20). "Press Release: Holmusk Announces Closing of US$21.5 Million Series A Funding Round, Led by Optum Ventures & Health Catalyst Capital". Singapore, London & New York, NY. 2020-05-18
CellGenix GmbH. (5/13/20). "Press Release: Ori Biotech and CellGenix to Collaborate in Order to Promote Innovation within Closed-system, Cell and Gene Therapy Manufacturing". Freiburg & London. 2020-05-13
Optibrium Ltd.. (5/12/20). "Press Release: Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific". Cambridge & Santa Fe, NM. 2020-05-12
Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels. 2020-05-12
Freeline Therapeutics Ltd.. (5/4/20). "Press Release: Freeline Receives Orphan Drug Designation from the FDA for FLT190 for the Treatment of Fabry Disease". London. 2020-05-04
[iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. 2020-05-04
Syncona Ltd.. (4/30/20). "Press Release: Danny Bar-Zohar Joins Syncona as Partner". 2020-04-30
Compass Pathways Ltd.. (4/27/20). "Press Release: Mental Health Care Company Compass Pathways Concludes Successful Series B Investment Round. $80m Raised Will Further the Development of Psilocybin Therapy". London. 2020-04-27
Bicycle Therapeutics plc. (4/23/20). "Press Release: Bicycle Therapeutics Appoints Zafar Qadir as General Counsel". Cambridge & Boston, MA. 2020-04-23
UK Innovation & Science Seed Fund (UKI2S). (4/22/20). "Press Release: MicrofluidX Raises £1.4m in Seed Funding to Develop Novel Cell Therapy Bioprocessing Technology". Basel. 2020-04-22
Cell Mogrify Ltd.. (4/21/20). "Press Release: Mogrify and Sangamo Announce Collaboration and Exclusive License Agreement for Mogrify’s iPSC- and ESC-derived Regulatory T Cells". Cambridge & Brisbane, CA. 2020-04-21
Nanna Therapeutics Ltd.. (4/21/20). "Press Release: Astellas Announces Acquisition of Nanna". Tokyo & Cambridge. 2020-04-21
Avectas Ltd.. (4/16/20). "Press Release: Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million". Dublin. 2020-04-16
Cevec Pharmaceuticals GmbH. (4/16/20). "Press Release: Cevec Signs License Agreement for the Development and Commercialization of Exosomes for Therapeutic Use". Cologne. 2020-04-16
Halix B.V.. (4/15/20). "Press Release: Halix Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine". Leiden. 2020-04-15
Kymab Group Ltd.. (4/14/20). "Press Release: US Patent Trial and Appeal Board Rejects Requests Filed by Regeneron. USPTO Upholds 4 Kymab Patents Covering Human Antibodies and Platforms". Cambridge. 2020-04-14
GlaxoSmithKline plc. (4/14/20). "Press Release: Sanofi and GSK to Join Forces in Unprecedented Vaccine Collaboration to Fight COVID-19". London. 2020-04-14
Cerevance. (4/14/20). "Press Release: Cerevance Closes $45 Million Series B Financing". Boston, MA. 2020-04-14
Avectas Ltd.. (4/8/20). "Press Release: Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office". Dublin. 2020-04-08
Gadeta B.V.. (4/7/20). "Press Release: Gadeta Appoints Marco Londei as Chief Executive Officer". Utrecht. 2020-04-07
Amphista Therapetuics. (4/7/20). "Press Release: Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer". Glasgow. 2020-04-07
Sutura Therapeutics Ltd.. (4/6/20). "Press Release: Sutura Therapeutics Appoints Alex Smith as Head of Patient Advocacy". Birkenhead. 2020-04-06
Evotec SE. (4/6/20). "Press Release: Evotec Expands into Gene Therapy. Evotec Establishes Gene Therapy R&D Site with more than 20 Experienced Scientis in Austria". Hamburg. 2020-04-06
Izana Bioscience Ltd.. (4/6/20). "Press Release: Initiation of Two-centre Compassionate Use Study Involving Namilumab in the Treatment of Individual Patients with Rapidly Worsening COVID-19 Infection in Italy". Oxford. 2020-04-06
GlaxoSmithKline plc. (4/6/20). "Press Release: GSK and Vir Biotechnology Enter Collaboration to Find Coronavirus Solutions". London & San Francisco, CA. 2020-04-06
Actimed Therapeutics Ltd.. (4/2/20). "Press Release: Actimed Therapeutics Appoints Annalisa Jenkins as Advisor". London. 2020-04-02
ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. 2020-04-02
Sutura Therapeutics Ltd.. (4/1/20). "Press Release: Sutura Therapeutics Appoints Mark Beards as Chief Executive Officer". Birkenhead. 2020-04-01
Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC. 2020-03-31
Exscientia Ltd.. (3/31/20). "Press Release: Exscientia Announces Joint Initiative to Identify COVID-19 Drugs with Diamond Light Source and Scripps Research". 2020-03-31
Sitryx Therapeutics Ltd.. (3/31/20). "Press Release: Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines". Indianapolis, IN & Oxford. 2020-03-31
Owlstone Medical Ltd.. (3/30/20). "Press Release: Owlstone Medical Appoints Neil Tween as Chief Financial Officer". Cambridge. 2020-03-30
ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA. 2020-03-30
Immune Regulation Ltd.. (3/27/20). "Press Release: Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer". 2020-03-27
Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. 2020-03-27
Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. 2020-03-26
Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration". 2020-03-26
SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA. 2020-03-26
Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020". 2020-03-26
Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London. 2020-03-25
Proteona Pte. Ltd.. (25/3/20). "Press Release: Proteona Leads International Consortium to Develop SARS-CoV-2 Neutralizing Antibody to Help Vulnerable Immunocompromised Individuals". Singapore. 2020-03-25
Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces Collaboration with AstraZeneca to Discover and Develop siRNA Therapeutics for Cardiovascular, Renal, Metabolic and Respiratory Diseases". London. 2020-03-25
Oxford BioMedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. 2020-03-18
Oxford BioMedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford. 2020-03-18
Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. 2020-03-17
Immatics Biotechnologies GmbH. (3/17/20). "Press Release: Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies". Houston, TX & Tübingen. 2020-03-17
NeoPhore Ltd.. (3/17/20). "Press Release: NeoPhore Appoints Dr Matthew Baker as Chief Executive Officer". Cambridge. 2020-03-17
Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. 2020-03-10
MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. 2020-03-09
Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford. 2020-03-09
MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. 2020-03-06
Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. 2020-03-04
Fluidigm Corporation. (3/3/20). "Press Release: Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing". South San Francisco, CA & Hinxton. 2020-03-03
Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Advanced Liquid Chromatography System Delivers Productivity, Precision and Compliance in Routine Analyses". Germering. 2020-03-02
Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Enterprise-Level Chromatography Data System Software Enhances Laboratory Efficiency, Compliance and Standardization". San José, CA. 2020-03-02
Immunocore Ltd.. (3/2/20). "Press Release: Immunocore Secures $130 Million Series B Financing". Oxfordshire & Conshohocken, PA. 2020-03-02
Sutura Therapeutics Ltd.. (3/2/20). "Press Release: Sutura Therapeutics Appoints James Noble and Eduardo Bravo to Board of Directors". Birkenhead. 2020-03-02
CN Bio Innovations Ltd.. (3/2/20). "Press Release: CN Bio Innovations Raises $9 Million USD (c. £6.9 Million GBP)". Cambridge. 2020-03-02
Evonetix Ltd.. (3/2/20). "Press Release: Evonetix Raises $30 Million USD (£23 Million GBP)". Cambridge. 2020-03-02
Cambridge Cancer Genomics Ltd.. (2/28/20). "Press Release: Precision-Panc and CCG.ai Partnership". Cambridge & Glasgow. 2020-02-28
Genedata AG. (2/26/20). "Press Release: Leading Biopharma Experts Drive R&D Innovation and Process Efficiency at the Genedata Partner Symposium". Basel. 2020-02-26
Coulter Partners. (2/26/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for Centogene". 2020-02-26
Domainex Ltd.. (2/25/20). "Press Release: Lunac Therapeutics Selects Domainex as Its Strategic Drug Discovery Partner". Cambridge & Leeds. 2020-02-25
Bicycle Therapeutics plc. (2/25/20). "Press Release: Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle-based Immuno-oncology Therapies". Cambridge & Boston, MA. 2020-02-25
FinnGen. (2/25/20). "Press Release: FinnGen Welcomes Janssen and Maze Therapeutics". 2020-02-25
Sanofi S.A.. (2/24/20). "Press Release: Sanofi to Create New Industry Leading European Company to Provide Active Pharmaceutical Ingredients (API)". Paris. 2020-02-24
CTC North GmbH & Co. KG. (2/20/20). "Press Release: Hope for Hepatitis B Patients. New Research Project to Cure Hepatitis B Patients under the European Horizon 2020 Programme". 2020-02-20
Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. 2020-02-20
Scottish Enterprise. (2/17/20). "Press Release: Deputy First Minister Announces £9.5 Million to Compete in Global Precision Medicine Industry". 2020-02-17
Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. 2020-02-17
Edinburgh Innovations. (2/17/20). "Press Release: Spinout Takes Aim at Treatments for Multiple Sclerosis". 2020-02-17
TrakCel Ltd.. (2/17/20). "Press Release: TrakCel Appoints Dr Fiona Withey as Chief Executive Officer". Cardiff. 2020-02-17
PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. 2020-02-17
OMass Therapeutics Ltd.. (2/17/20). "Press Release: OMass Therapeutics Announces £27.5 Million Extended Series A Financing". Oxford. 2020-02-17
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Is Pleased to Announce an Investment in Neurofenix, an Innovative Digital Health Company". Cambridge. 2020-02-15
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Pencil Biosciences, a Novel Gene Modulation Biotech". Cambridge. 2020-02-15
o2h Ventures. (2/15/20). "Press Release: o2h Ventures Makes an Investment in Turbine". Cambridge. 2020-02-15
Domainex Ltd.. (2/13/20). "Press Release: Domainex Announces the Appointment of Tom Mander as Chief Executive Officer". Cambridge. 2020-02-13
Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London. 2020-02-12
Lexington Communications. (2/12/20). "Press Release: Leading Strategy and Public Affairs Consultancy Opens New Office in Cambridge". 2020-02-12
ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. 2020-02-11
Fluidigm Corporation. (2/10/20). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results". South San Francisco, CA. 2020-02-10
ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. 2020-02-10
Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. 2020-02-04
Inato. (2/4/20). "Press Release: Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures". Paris. 2020-02-04
Exscientia Ltd.. (1/30/20). "Press Release: Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial". 2020-01-30
Coulter Partners. (1/28/20). "Press Release: Coulter Partners Secures Chief Financial Officer for Stilla Technologies". 2020-01-28
Quench Bio. (1/27/20). "Press Release: Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases". Cambridge, MA. 2020-01-27
Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln. 2020-01-24
Ervaxx Ltd.. (1/24/20). "Press Release: Ervaxx and Cardiff University Enter Collaboration to Develop novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens". London. 2020-01-24
Oxford University Innovation. (1/23/20). "Press Release: Oxford Investment Opportunity Network and Oxford Angel Network Join Forces". 2020-01-23
PureTech Health plc. (1/23/20). "Press Release: PureTech Receives $200 Million from Sale of a Minority Portion of Affiliate Shares". 2020-01-23
iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. 2020-01-23
Coulter Partners. (1/22/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for OxStem". 2020-01-22
Horizon Therapeutics plc. (1/21/20). "Press Release: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)". Dublin. 2020-01-21
Exscientia Ltd.. (1/21/20). "Press Release: Exscientia Appoints Dr. David Hallett as Chief Operating Officer as Company Positions for Further Growth". 2020-01-21
1 2 3 ... 42 43 44  next pagenext page



Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] Made Without Love 650x80px

» top